XERS · Company research
Xeris Biopharma Holdings, Inc. Common Stock (XERS): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 10.07 | $1,724,778,080.9 | 1603031080.90 | — | — | — | — | — | 214.15173589520735038468 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.